Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 30;25(9):2102.
doi: 10.3390/molecules25092102.

Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment

Affiliations
Review

Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment

Manuela Curcio et al. Molecules. .

Abstract

Carbon nanostructures (CN) are emerging valuable materials for the assembly of highly engineered multifunctional nanovehicles for cancer therapy, in particular for counteracting the insurgence of multi-drug resistance (MDR). In this regard, carbon nanotubes (CNT), graphene oxide (GO), and fullerenes (F) have been proposed as promising materials due to their superior physical, chemical, and biological features. The possibility to easily modify their surface, conferring tailored properties, allows different CN derivatives to be synthesized. Although many studies have explored this topic, a comprehensive review evaluating the beneficial use of functionalized CNT vs G or F is still missing. Within this paper, the most relevant examples of CN-based nanosystems proposed for MDR reversal are reviewed, taking into consideration the functionalization routes, as well as the biological mechanisms involved and the possible toxicity concerns. The main aim is to understand which functional CN represents the most promising strategy to be further investigated for overcoming MDR in cancer.

Keywords: cancer therapy; carbon nanohybrids; carbon nanostructures; multi-drug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
General representation of the main MDR reversal mechanisms by nanoparticle systems (NP). Reproduced with permission from [4]. Copyright Elsevier (2017)
Figure 2
Figure 2
Schematic representation of the main carbon nanostructures covalent functionalization routes. CNT: carbon nanotubes; G: graphene; F: fullerenes. For each reaction, number codes and derivatizing agents are reported in Table 1.
Figure 3
Figure 3
General representation of the main mechanisms involved in the CNT cellular uptake. Reproduced with permission from [137] Elsevier (2016).
Figure 4
Figure 4
General representation of photothermal therapy by G derivatives. Adapted with permission from [198] copyright Elsevier (2018).

References

    1. Frank D., Tyagi C., Tomar L., Choonara Y.E., du Toit L.C., Kumar P., Penny C., Pillay V. Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int. J. Nanomed. 2014;9:589–613. doi: 10.2147/Ijn.S50941. - DOI - PMC - PubMed
    1. Iyer A.K., Singh A., Ganta S., Amiji M.M. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Deliver. Rev. 2013;65:1784–1802. doi: 10.1016/j.addr.2013.07.012. - DOI - PubMed
    1. Tsuruo T., Naito M., Tomida A., Fujita N., Mashima T., Sakamoto H., Haga N. Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal. Cancer Sci. 2003;94:15–21. doi: 10.1111/j.1349-7006.2003.tb01345.x. - DOI - PMC - PubMed
    1. Singh M.S., Tammam S.N., Boushehri M.A.S., Lamprecht A. MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers. Pharmacol. Res. 2017;126:2–30. doi: 10.1016/j.phrs.2017.07.023. - DOI - PubMed
    1. Fojo T., Bates S. Strategies for reversing drug resistance. Oncogene. 2003;22:7512–7523. doi: 10.1038/sj.onc.1206951. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources